首页> 外国专利> Pharmaceutical composition having enhanced antitumour activity and/ or reduced side effects, containing an antitumour agent and an hydroximic acid derivative

Pharmaceutical composition having enhanced antitumour activity and/ or reduced side effects, containing an antitumour agent and an hydroximic acid derivative

机译:具有增强的抗肿瘤活性和/或减少的副作用的药物组合物,其包含抗肿瘤剂和羟肟酸衍生物

摘要

The invention refers to pharmaceutical compositions which have an enhanced antitumour activity and/or reduced side effect(s) comprising a known active substance having antitumour effect or a pharmaceutically acceptable salt thereof and a hydroximic acid derivative of formula (I) or a therapeutically useful acid addition salt thereof. Disclosed is also the use of the said active components for preparation of such pharmaceutical compositions and use of the hydroximic acid derivatives of formula (I) or therapeutically useful acid addition salt thereof for preparation of pharmaceutical composition, which reduces side effects of active substances with antitumour effect.
机译:本发明涉及具有增强的抗肿瘤活性和/或减少的副作用的药物组合物,其包含具有抗肿瘤作用的已知活性物质或其药学上可接受的盐以及式(I)的氢氧酸衍生物或可用于治疗的酸其加成盐。还公开了所述活性成分在制备此类药物组合物中的用途以及式(I)的氢氧酸衍生物或其治疗上有用的酸加成盐在制备药物组合物中的用途,其减少了活性物质具有抗肿瘤作用的副作用。影响。

著录项

  • 公开/公告号SK282877B6

    专利类型

  • 公开/公告日2003-01-09

    原文格式PDF

  • 申请/专利权人 N-GENE RESEARCH LABORATORIES INC.;

    申请/专利号SK176499A

  • 发明设计人 SUMEGI BALAZS;

    申请日1998-06-22

  • 分类号A61K45/06;

  • 国家 SK

  • 入库时间 2022-08-22 00:01:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号